Brainstim Health
BrainStim Health is a Canadian private interventional psychiatry clinic operator running seven sites across Canada, offering Deep TMS and ketamine-assisted psychotherapy to treatment-resistant patients, with a primary focus on veterans and first responders.
- Company typePrivate
- Founded2017
- HeadquartersVancouver, Canada
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Brainstim Health does
BrainStim Health is a Canadian private interventional psychiatry operator founded in 2017 and headquartered in Vancouver, British Columbia. The company runs a network of seven clinics across Canada (Vancouver, South Surrey, Halifax, Kingston, Ottawa, Calgary, and Perth) with a publicly stated plan to expand to ten clinics during 2026 (adding Edmonton, Markham, and Victoria). Its clinical offering centers on two modalities: Deep Transcranial Magnetic Stimulation (Deep TMS) using BrainsWay H-coil technology, and ketamine-assisted psychotherapy, supported by conventional psychotherapy (CBT and trauma-focused therapy). Indications addressed include treatment-resistant depression, PTSD, OCD, anxiety disorders, addiction, chronic pain, ADHD, and trauma, with a stated emphasis on patients who have not responded to medication and standard psychotherapy.
The company's primary customer segments are veterans and first responders — served through a dedicated program, a referral partnership with Veterans Affairs Canada, and a co-developed rTMS research collaboration with the Legion Veterans Village Research Foundation — alongside treatment-resistant depression patients in the general population. Revenue is generated on a fee-for-service basis at approximately $7,000 per TMS course, with patient financing offered through a Medicard partnership and partial coverage available via VAC and extended health plans. According to company materials, BrainStim has treated more than 1,000 patients and reports response rates up to 70% for treatment-resistant depression and 50-60% symptom reduction. Distribution is direct-to-patient via clinics, supplemented by a free 15-minute virtual consultation funnel, online self-referral, and healthcare-provider referrals. BrainStim holds minority equity investment from BrainsWay Ltd. ($1 million closed in February 2026, with up to $1.5 million in milestone-based follow-on), and the company is privately held.
Brainstim Health firmographics
Firmographics- Name
- Brainstim Health
- Legal name
- BrainStim Health
- Website
- https://brainstim.ca
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BrainStim Health is a Canadian private interventional psychiatry clinic operator running seven sites across Canada, offering Deep TMS and ketamine-assisted psychotherapy to treatment-resistant patients, with a primary focus on veterans and first responders.
- Ownership category
- akta.pro rank
Brainstim Health industry classification
Industry- Product category
- Mental Health Services
- NAICS
- Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Psychiatry & Medication Management Platforms (HLALAEAB)
- akta.pro secondary industry
- General Mental Health Therapy Platforms (Talk Therapy) (HLALAEAA)
Keywords
Where Brainstim Health is headquartered
LocationHeadquarters
- HQ city
- Vancouver
- HQ country
- Canada
- HQ region
- North America
Offices7 records
Markets served
Brainstim Health business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Clinical Treatment Services: BrainStim generates revenue through providing Deep TMS treatments, ketamine-assisted psychotherapy, and other mental health services at their clinics across Canada. Services include initial psychiatric evaluations, treatment sessions, and ongoing maintenance care. Treatment cost approximately $7,000 per course.
- Ketamine Therapy Sessions: Revenue from psychedelic therapy sessions administered via IV infusion, IM injection, or oral lozenges, typically 6 sessions over 3-6 weeks for depression treatment.
- Payment Plans: Partnership with Medicard provides monthly payment plans allowing patients to spread treatment costs over time.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Deep TMS Treatment Course |
| Subscription | Monthly | Monthly Payment Plans |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Brainstim Health product offering
Product offeringCore offering
BrainStim Health operates a network of mental health clinics across Canada delivering advanced neurostimulation and psychedelic-assisted treatments for treatment-resistant mental health conditions. The core clinical offerings are Deep Transcranial Magnetic Stimulation (Deep TMS) and Ketamine-Assisted Psychotherapy, supported by traditional psychotherapy services. Treatments are provided by psychiatrist-led multidisciplinary teams and target conditions including treatment-resistant depression, PTSD, OCD, anxiety, addiction, chronic pain, ADHD, and trauma.
Product overview
BrainStim Health operates a network of mental health clinics across Canada offering advanced neurostimulation and psychedelic-assisted therapy treatments. The company's core offerings consist of Deep TMS (Deep Transcranial Magnetic Stimulation) — a non-invasive brain stimulation treatment — and Ketamine-Assisted Psychotherapy, supported by traditional psychotherapy services. These treatments are delivered through a network of 7 clinics across Canada (Vancouver, South Surrey, Halifax, Kingston, Ottawa, Calgary, and Perth), with a specialized Veterans & First Responders Program addressing trauma, PTSD, and related conditions. The treatment portfolio covers treatment-resistant depression, PTSD, OCD, anxiety disorders, addiction, chronic pain, ADHD, and trauma. BrainStim positions itself as an interventional psychiatry practice offering alternatives to traditional medication-based treatments.
Differentiator
Problem solved
Functional benefit
Products and services
- Deep TMS (Deep Transcranial Magnetic Stimulation)
Quantifiable outcome
- Up to 70% response rate for treatment-resistant depression
- +3 more outcomes
Companies that use Brainstim Health
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles2 records
Brainstim Health technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature4 records
Brainstim Health partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered flagship, minor and core.
- Legion Veterans Village Research FoundationflagshipPartnership to investigate a new brain stimulation program using repetitive transcranial magnetic stimulation (rTMS) for veterans in British Columbia struggling with PTSD and chronic pain. Recruitment is open for eligible veterans. BrainStim works with Veterans Affairs Canada and assists eligible veterans with navigating benefit coverage.
- MedicardminorMedicard provides easy and affordable payment plans allowing patients to pay for treatments and procedures on a monthly basis, spreading costs over time with manageable payments.
- Veterans Affairs Canada (VAC)coreBrainStim works with Veterans Affairs Canada and assists eligible veterans with navigating their benefit coverage for mental health treatments including TMS therapy.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
Brainstim Health competitors and assessment
Company assessmentBroad incumbents
- BetterHelp: BetterHelp is the largest online talk-therapy platform. While a delivery-model outlier versus BrainStim, it is a comparable adjacent incumbent in the mental-health services category where BrainStim also offers psychotherapy alongside its interventional offerings.
- Neuronetics: Neuronetics is the publicly-listed maker of the NeuroStar TMS system and the dominant US TMS device vendor. Comparable to BrainStim as a TMS ecosystem incumbent and through its affiliated clinical service programs, and as a competitive device alternative to BrainsWay's H-coil platform.
- BrainsWay Ltd. BrainsWay is the publicly-listed manufacturer of Deep TMS H-coil devices and a current strategic minority investor in BrainStim. It is comparable both as the underlying technology vendor that enables BrainStim's core service and as a clinical-platform sponsor (with several TMS clinic minority investments).
Direct peers
- Field Trip Health: Field Trip Health was a Canadian-headquartered operator of psychedelic-assisted therapy clinics combining ketamine and integration psychotherapy. Closely comparable to BrainStim on geography (Canada), interventional psychiatry positioning, and combination of ketamine with psychotherapy.
- Greenbrook TMS NeuroHealth Centers: Greenbrook operates the largest US network of physician-supervised TMS treatment centers for depression, OCD, and related conditions. Directly comparable to BrainStim as a multi-site TMS clinic operator with a focus on treatment-resistant mental health.
- Ketamine Clinics of LA (KCLA): KCLA is one of the longest-running independent ketamine therapy clinic operators in the US, treating depression, PTSD, anxiety, and chronic pain. Directly comparable to BrainStim's ketamine-assisted psychotherapy service line and treatment-resistant mental-health positioning.
- Apollo TMS International: Apollo TMS operates TMS treatment centers focused on mental health and chronic pain across multiple US markets. Comparable as a multi-clinic TMS specialty operator serving similar treatment-resistant patient cohorts.
Emerging players
- Black Dog Institute / Black Dog TMS: Affiliated TMS clinical service programs in Australia focused on treatment-resistant depression and related disorders. Comparable as a specialist neuromodulation service operator and clinical-research venue for TMS in a non-US market.
- Mindbloom: Mindbloom is a US-based at-home ketamine therapy platform for depression, anxiety, and PTSD. Compares to BrainStim on the ketamine-for-treatment-resistant-depression value proposition and target patient population, though delivering via telehealth rather than in-clinic.
Others
- Spring Health: Spring Health is a global mental health benefits and care-navigation platform used by employers and payers. Adjacent to BrainStim as a channel/payer that increasingly routes patients to specialty providers, and a potential strategic partner for referral volume.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Brainstim Health social profiles
Digital presenceBrainstim Health compliance and trust
Trust signalCompliance4 records
Brainstim Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Brainstim Health leadership team
Management profileNumber of profiles
Profiles7 records
Brainstim Health funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Brainstim Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Brainstim Health
What does Brainstim Health do?
BrainStim Health operates a network of mental health clinics across Canada delivering advanced neurostimulation and psychedelic-assisted treatments for treatment-resistant mental health conditions. The core clinical offerings are Deep Transcranial Magnetic Stimulation (Deep TMS) and Ketamine-Assisted Psychotherapy, supported by traditional psychotherapy services. Treatments are provided by psychiatrist-led multidisciplinary teams and target conditions including treatment-resistant depression, PTSD, OCD, anxiety, addiction, chronic pain, ADHD, and trauma.
Is Brainstim Health a public or private company?
Brainstim Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Brainstim Health founded?
Brainstim Health was founded in 2017. It employs 1 to 10 people.
Where is Brainstim Health based?
Brainstim Health is headquartered in Vancouver, Canada, in the North America region.
How does Brainstim Health make money?
Three revenue lines are on record. Clinical Treatment Services are the primary driver. The others are ketamine Therapy Sessions and payment Plans.
Who are Brainstim Health's main competitors?
Broad incumbents on record are BetterHelp, Neuronetics and BrainsWay Ltd.. Direct peers are Field Trip Health, Greenbrook TMS NeuroHealth Centers, Ketamine Clinics of LA (KCLA) and Apollo TMS International. Emerging players are Black Dog Institute / Black Dog TMS and Mindbloom. Spring Health is listed as an others.
Does Brainstim Health have an API?
No public API is recorded for Brainstim Health.
What industry is Brainstim Health in?
Brainstim Health's product category is Mental Health Services. Its primary akta.pro industry code is HLALAEAB, Psychiatry & Medication Management Platforms, with a secondary code of HLALAEAA, General Mental Health Therapy Platforms (Talk Therapy). Its NAICS code is 621112 and its SIC code is 8011.